Table:
begin	end	state
1	42	cytoplasmic
43	64	transmembrane
65	70	non-cytoplasmic
71	97	transmembrane
98	108	cytoplasmic
109	130	transmembrane
131	135	non-cytoplasmic
136	161	transmembrane
162	180	cytoplasmic
181	201	transmembrane
202	206	non-cytoplasmic
207	225	transmembrane
226	263	cytoplasmic
264	287	transmembrane
288	300	non-cytoplasmic
301	321	transmembrane
322	330	cytoplasmic
331	350	transmembrane
351	356	non-cytoplasmic
357	379	transmembrane
380	393	cytoplasmic
394	417	transmembrane
418	424	non-cytoplasmic
425	444	transmembrane
445	453	cytoplasmic

Input:
>BPHYT_RS07505 FitnessBrowser__BFirm:BPHYT_RS07505
MDYSATPQPAGTEALSMQSTPAAQPVERTSHVKAIAAITLGNGLEFFDFTIYSFFATIIG
KLYFPVEGQLAQLMLAVGTFGVGFIMRPVGGIVLGAYADRAGRKAAMSLTLWLMTLGSAI
IAFAPTYAAIGVAAPLLVILARLIQGFALGGEVGASTSLLLEYGSNKTRGFYGSWQFVSQ
GLNTVCGSLLGVALAAALSTAALESWGWRVPFVIGMAMGPIGIYIRRHLNETLPGVEDGA
AGSQPGSQPVSQPVRKLFREHSRVITTGVLTTIGGTAANYIVLFYLSTYAIRILHLPMSS
ALWAAWTAAVVTVICSPFAGALSDRVGRKRVLWVSRVLLIAAVYPAFMMINASPTVPVLL
AVVAGLAVLVAFTAVPNIVMLPEMFPREIRATGMSIVYCLGVSIFGGFAQFFATWLIQVS
GSNLAPAWYLIGCGVVSLLPLPFMRETAGRDIG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server